Results to your Biomarker

Biomarker
Exposure to
Matrix
Analytical Technique
3-Hydroxypropylmercapturic acid (3-HPMA)
Acrolein
Urine
LC-MS/MS

Matching services

biomonitoring

Biomonitoring

Human biomonitoring (HBM) is the determination of pollutants or their metabolites in biological material (blood, urine, saliva, etc.). With the help of HBM, the exposure to environmental chemicals can be assessed to identify vulnerable populations or regional differences.
tobacco

Tobacco Harm Reduction

Tobacco harm reduction is a public health strategy to lower the health risks to individuals and wider society associated with using tobacco products. Biomarkers specific for the exposure to tobacco and smoke are key endpoints for evaluating new emerging nicotine products with a potentially reduced risk.

Scientific Contribution

publication
May 2015

Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methods

Analytical and Bioanalytical Chemistry, Volume 407, doi: 10.1007/s00216-015-8719-x
Conference contribution
October 2014

Analysis of 18 Urinary Mercapturic Acids by two Multiplex-LC-MS/MS Methods

CORESTA Congress 2014, Quebec, Canada
Conference contribution
October 2017

Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients–results

CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2017

Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients – methods

CORESTA SSPT 2017, Kitzbühel, Austria
Conference contribution
October 2018

Novel biomarkers to characterize exposure to aldehydes from e-vapor products based on stable-isotope constituents

CORESTA Congress 2018, Kunming, China
Conference contribution
October 2018

Analytical methods for the determination of carbonyls in aerosol from e-vapor products and cigarette smoke and their urinary biomarkers of exposure

CORESTA Congress 2018, Kunming, China
Conference contribution
October 2019

Analysis of aldehydes, propylene oxide and glycidol in tobacco smoke and e-cigarette vapor and their respective urinary biomarkers

CORESTA SSPT 2019, Hamburg, Germany
Conference contribution
February 2018

Biomarkers of exposure specific to e-vapor products based on stable-isotope labeled ingredients

SRNT 2018, Baltimore, USA
Conference contribution
February 2019

Novel biomarkers to characterize the specific exposure to aldehydes or epoxides from e-vapor products based on stable-isotope labeled constituents

SRNT 2019, San Francisco, USA
publication
June 2021

Assessment of the potential vaping-related exposure to carbonyls and epoxides using stable isotope-labeled precursors in the e-liquid

Archives of Toxicology, doi:10.1007/s00204-021-03097-x
publication
October 2022

Comparison of urinary mercapturic acid excretions in users of various tobacco/nicotine products

Drug Testing and Analysis DOI: 10.1002/dta.3372